I have heard one story that it is not as certain as Uscom claim that their BP+ product will comply with the requirements of the CPT reimbursement criteria. FDA approval is not the same thing. Whether that story is right only time will tell, but it was enough to put me off.
I have heard one story that it is not as certain as Uscom claim...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UCM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.506M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150000 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.12pm 29/11/2024 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable
